| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Departments of Medicine [W. E-R., M. F. S., G. L., A. B., V. S. C., S. M. P.], Microbiology [M. F. S.], and Pathology [C. A. M., H. F. F.], University of Virginia Health System, Charlottesville, Virginia 22908-0708; Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21230 [E. M.]; and Department of Medical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, 00290 Finland [S. K.]
Gastric carcinoma is the second most common cause of cancer-related death worldwide. Recently, we have demonstrated that expressed sequencetag AA552509 was frequently amplified and the most consistently overexpressed target at 17q in gastric cancers. Herein, we report that DARPP-32 (dopamine and cAMP-regulated phosphoprotein of Mr 32,000) is the target gene for overexpression of expressed sequence tag AA552509. In addition, we have identified full-length cDNA of DARPP-32 (GenBank accession number AF464196) with 467 bp of additional untranslated mRNA nucleotides upstream of the previously known translation start site in exon 1. Additionally, we have discovered a novel truncated isoform of DARPP-32 that we named t-DARPP (GenBank accession number AY070271), which is also overexpressed in gastric cancers. Using quantitative real-time reverse transcription-PCR, Western blots, and staining of tumor tissue arrays, the two DARPP mRNA transcripts and proteins were overexpressed in gastric cancer cells and exhibited abundant protein overexpression in neoplastic but not normal gastric epithelial cells. DARPP-32 is the only known protein that acts as a protein phosphatase 1 inhibitor or a protein kinase A inhibitor. The novel truncated isoform, t-DARPP, lacks the phosphorylation site related to protein phosphatase 1 inhibition but maintains the phosphorylation site with the protein kinase A inhibitory effect. Our results reveal for the first time the presence of these signaling molecules in human cancer and suggest that they may be important for gastric tumorigenesis.
This article has been cited by other articles:
![]() |
L. Gu, S. K. Lau, S. Loera, G. Somlo, and S. E. Kane Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines Clin. Cancer Res., December 1, 2009; 15(23): 7196 - 7206. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hansen, J. Howlin, A. Tengholm, O. Dyachok, W. F. Vogel, A. C. Nairn, P. Greengard, and T. Andersson Wnt-5a-induced Phosphorylation of DARPP-32 Inhibits Breast Cancer Cell Migration in a CREB-dependent Manner J. Biol. Chem., October 2, 2009; 284(40): 27533 - 27543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belkhiri, A. A. Dar, D. F. Peng, M. H. Razvi, C. Rinehart, C. L. Arteaga, and W. El-Rifai Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells Clin. Cancer Res., July 15, 2008; 14(14): 4564 - 4571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belkhiri, A. A. Dar, A. Zaika, M. Kelley, and W. El-Rifai t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism Cancer Res., January 15, 2008; 68(2): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maqani, A. Belkhiri, C. Moskaluk, S. Knuutila, A. A. Dar, and W. El-Rifai Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas Mol. Cancer Res., July 1, 2006; 4(7): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Kauraniemi and A Kallioniemi Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr. Relat. Cancer, March 1, 2006; 13(1): 39 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Jimenez, M. A. Zaballos, and P. Santisteban DARPP-32 (Dopamine and 3',5'-Cyclic Adenosine Monophosphate-Regulated Neuronal Phosphoprotein) Is Essential for the Maintenance of Thyroid Differentiation Mol. Endocrinol., December 1, 2005; 19(12): 3060 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belkhiri, A. Zaika, N. Pidkovka, S. Knuutila, C. Moskaluk, and W. El-Rifai Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas Cancer Res., August 1, 2005; 65(15): 6583 - 6592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Johnson, H. F. Frierson, A. Zaika, S. M. Powell, J. Roche, S. Crowe, C. A. Moskaluk, and W. El-Rifai Expression of Tight-Junction Protein Claudin-7 Is an Early Event in Gastric Tumorigenesis Am. J. Pathol., August 1, 2005; 167(2): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Malta-Vacas, C Aires, P Costa, A R Conde, S Ramos, A P Martins, C Monteiro, and M Brito Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types J. Clin. Pathol., June 1, 2005; 58(6): 621 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Koon, R Schneider-Stock, M Sarlomo-Rikala, J Lasota, M Smolkin, G Petroni, A Zaika, C Boltze, F Meyer, L Andersson, et al. Molecular targets for tumour progression in gastrointestinal stromal tumours Gut, February 1, 2004; 53(2): 235 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.'e. El-Rifai, C. A. Moskaluk, M. K. Abdrabbo, J. Harper, C. Yoshida, G. J. Riggins, H. F. Frierson Jr., and S. M. Powell Gastric Cancers Overexpress S100A Calcium-binding Proteins Cancer Res., December 1, 2002; 62(23): 6823 - 6826. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |